Precision Biosciences (DTIL) Short-term Investments (2024 - 2026)
Precision Biosciences' (DTIL) quarterly Short-term Investments came in at $1.8 million in Q1 2026, down 61.91% on a QoQ basis from $4.8 million in Q4 2025.
Precision Biosciences (DTIL) Short-term Investments (2024 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 3 years of Short-term Investments data on file, last reported at $1.8 million in Q1 2026.
- On a quarterly basis, Short-term Investments changed N/A year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.8 million, up 1053.03% from the prior year.
- Short-term Investments for Q1 2026 stood at $1.8 million, down from $4.8 million in the prior quarter.
- Over the last five years, Short-term Investments for DTIL reached as high as $4.8 million in Q4 2025 and fell as low as $413000.0 in Q4 2024.
- Historically, Short-term Investments has averaged $2.4 million across 3 years, with a median of $2.1 million in 2024.
- On a YoY basis, Short-term Investments climbed as much as 1053.03% in 2025 and fell as far as 1053.03% in 2025.
- Year by year, Short-term Investments stood at $413000.0 in 2024, then soared by 1053.03% to $4.8 million in 2025, then tumbled by 61.91% to $1.8 million in 2026.
- Per Business Quant data, the three most recent Short-term Investments figures were $1.8 million in Q1 2026, $4.8 million in Q4 2025, and $413000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Precision Biosciences | 178.85 Mn | 150.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | 4.76 Mn |
| Dec 31, 2024 | 413,000.00 |
| Sep 30, 2024 | 2.45 Mn |